Literature DB >> 18424439

Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells.

Safak Yalcin1, Xin Zhang, Julia P Luciano, Sathish Kumar Mungamuri, Dragan Marinkovic, Cécile Vercherat, Abby Sarkar, Marcos Grisotto, Reshma Taneja, Saghi Ghaffari.   

Abstract

Unchecked accumulation of reactive oxygen species (ROS) compromises maintenance of hematopoietic stem cells. Regulation of ROS by the tumor suppressor protein ataxia telangiectasia mutated (ATM) is critical for preserving the hematopoietic stem cell pool. In this study we demonstrate that the Foxo3 member of the Forkhead Box O (FoxO) family of transcription factors is essential for normal ATM expression. In addition, we show that loss of Foxo3 leads to defects in hematopoietic stem cells, and these defects result from an overaccumulation of ROS. Foxo3 suppression of ROS in hematopoietic stem cells is mediated partly by regulation of ATM expression. We identify ROS-independent modulations of ATM and p16(INK4a) and ROS-mediated activation of p53/p21(CIP1/WAF1/Sdi1) tumor suppressor pathways as major contributors to Foxo3-null hematopoietic stem cells defects. Our studies demonstrate that Foxo3 represses ROS in part via regulation of ATM and that this repression is required for maintenance of the hematopoietic stem cell pool.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424439     DOI: 10.1074/jbc.M800517200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  123 in total

1.  Gfer is a critical regulator of HSC proliferation.

Authors:  Uma Sankar; Anthony R Means
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 2.  Mechanisms of self-renewal in hematopoietic stem cells.

Authors:  Zhao Wang; Hideo Ema
Journal:  Int J Hematol       Date:  2015-12-12       Impact factor: 2.490

Review 3.  Mitochondria and FOXO3 in stem cell homeostasis, a window into hematopoietic stem cell fate determination.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  J Bioenerg Biomembr       Date:  2017-06-21       Impact factor: 2.945

4.  A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids.

Authors:  Sangderk Lee; Nima M Gharavi; Henry Honda; Irene Chang; Brandon Kim; Nelson Jen; Rongsong Li; Alejandro Zimman; Judith A Berliner
Journal:  Free Radic Biol Med       Date:  2009-04-16       Impact factor: 7.376

Review 5.  Hematopoietic stem cell injury induced by ionizing radiation.

Authors:  Lijian Shao; Yi Luo; Daohong Zhou
Journal:  Antioxid Redox Signal       Date:  2014-02-10       Impact factor: 8.401

6.  Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury.

Authors:  Yong Wang; Lingbo Liu; Daohong Zhou
Journal:  Radiat Res       Date:  2011-10-20       Impact factor: 2.841

7.  AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias.

Authors:  Stephen M Sykes; Steven W Lane; Lars Bullinger; Demetrios Kalaitzidis; Rushdia Yusuf; Borja Saez; Francesca Ferraro; Francois Mercier; Harshabad Singh; Kristina M Brumme; Sanket S Acharya; Claudia Scholl; Claudia Schöll; Zuzana Tothova; Eyal C Attar; Stefan Fröhling; Ronald A DePinho; Scott A Armstrong; D Gary Gilliland; David T Scadden
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

Review 8.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

Review 9.  DNA damage response in adult stem cells: pathways and consequences.

Authors:  Pankaj K Mandal; Cédric Blanpain; Derrick J Rossi
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02-09       Impact factor: 94.444

Review 10.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.